Evidence map›Paper›PMID 35579965›Full record

ArticleJCI insight2022

Neutralizing antibody activity against SARS-CoV-2 variants in gestational age-matched mother-infant dyads after infection or vaccination.

Yusuke Matsui, Lin Li, Mary Prahl, Arianna G Cassidy, Nida Ozarslan, Yarden Golan, Veronica J Gonzalez, Christine Y Lin, Unurzul Jigmeddagva, Megan A Chidboy and 25 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Hybrid response to SARS-CoV-2 andHuman vaccines & immunotherapeutics · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Transplacental transfer of anti-SARS-CoV-2 neutralizing antibodies in comparison to other pathogens total antibodies.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2023
    Article
  16. Review
  17. Maternal and Perinatal Outcomes of SARS-CoV-2 and Variants in Pregnancy.Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 11 institutions in 1 country.

Yusuke MatsuiGladstone Institute of Virology, Gladstone Institutes, San Francisco, California, USA.
Lin LiDivision of Maternal-Fetal Medicine and.
Mary PrahlDepartment of Pediatrics.
Arianna G CassidyDivision of Maternal-Fetal Medicine and.
Nida OzarslanDivision of Maternal-Fetal Medicine and.
Yarden GolanDepartment of Bioengineering and Therapeutic Sciences.
Veronica J GonzalezDivision of Maternal-Fetal Medicine and.
Christine Y LinDivision of Maternal-Fetal Medicine and.
Unurzul JigmeddagvaCenter for Reproductive Sciences, Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, California, USA.
Megan A ChidboyDivision of Maternal-Fetal Medicine and.
Mauricio MontanoGladstone Institute of Virology, Gladstone Institutes, San Francisco, California, USA.
Taha Y TahaGladstone Institute of Virology, Gladstone Institutes, San Francisco, California, USA.
Mir M KhalidGladstone Institute of Virology, Gladstone Institutes, San Francisco, California, USA.
Bharath SreekumarGladstone Institute of Virology, Gladstone Institutes, San Francisco, California, USA.
Jennifer M HayashiGladstone Institute of Virology, Gladstone Institutes, San Francisco, California, USA.
Pei-Yi ChenGladstone Institute of Virology, Gladstone Institutes, San Francisco, California, USA.
G Renuka KumarGladstone Institute of Virology, Gladstone Institutes, San Francisco, California, USA.
Lakshmi WarrierDepartment of Family Health Care Nursing, and.
Alan Hb WuDepartment of Laboratory Medicine, UCSF, San Francisco, California, USA.
Dongli SongDepartment of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA.
Priya JegatheesanDepartment of Pediatrics, Division of Neonatology, Santa Clara Valley Medical Center, San Jose, California, USA.
Daljeet S RaiStanford-O'Connor Family Medicine Residency Program, Division of Family Medicine, Stanford University, Palo Alto, California, USA.
Balaji GovindaswamiDepartment of Pediatrics, Division of Neonatology, and.
Jordan NeedensDepartment of Obstetrics and Gynecology, Marshall University Joan C. Edwards School of Medicine, Huntington, West Virginia, USA.
Monica RinconDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA.
Leslie MyattDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA.
Ifeyinwa V AsioduDepartment of Family Health Care Nursing, and.
Valerie J FlahermanDepartment of Pediatrics.
Yalda AfsharDepartment of Obstetrics and Gynecology, UCLA, Los Angeles, California, USA.
Vanessa L JacobyDepartment of Obstetrics, Gynecology & Reproductive Sciences.
Amy P MurthaDivision of Maternal-Fetal Medicine and.
Joshua F RobinsonCenter for Reproductive Sciences, Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, California, USA.
Melanie OttGladstone Institute of Virology, Gladstone Institutes, San Francisco, California, USA.
Warner C GreeneGladstone Institute of Virology, Gladstone Institutes, San Francisco, California, USA.
Stephanie L GawDivision of Maternal-Fetal Medicine and.
Gladstone Institutes · USSociety for Maternal-Fetal Medicine · USFamily Healthcare · USOregon Health & Science University · USPediatrics and Genetics · USReproductive Science Center · USSanta Clara Valley Medical Center · USCenter for Global Health · USMarshall University · USStanford Medicine · USUniversity of California, San Francisco · US

Funding

UCSF/Kaiser-DOR Program for Developing Independent Women's Health ResearchersK12HD052163 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ADLER, NANCY E, BRINDIS, CLAIRE D. · 2005 to 2023
$9.3M
The Immunologic Impact of In Utero Malaria Exposure and Prenatal ChemopreventionK23AI127886 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PRAHL, MARY · 2017 to 2021
$1.0M
Placental malaria: The role of inflammation at the maternal-fetal interfaceK08AI141728 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GAW, STEPHANIE LINA · 2019 to 2023
$950k
NIAID NIH HHS K08 AI141728NIAID NIH HHS K23 AI127886NICHD NIH HHS K12 HD052163
6 · The paper itself

Abstract

Pregnancy confers unique immune responses to infection and vaccination across gestation. To date, there are limited data comparing vaccine- and infection-induced neutralizing Abs (nAbs) against COVID-19 variants in mothers during pregnancy. We analyzed paired maternal and cord plasma samples from 60 pregnant individuals. Thirty women vaccinated with mRNA vaccines (from December 2020 through August 2021) were matched with 30 naturally infected women (from March 2020 through January 2021) by gestational age of exposure. Neutralization activity against the 5 SARS-CoV-2 spike sequences was measured by a SARS-CoV-2-pseudotyped spike virion assay. Effective nAbs against SARS-CoV-2 were present in maternal and cord plasma after both infection and vaccination. Compared with WT spike protein, these nAbs were less effective against the Delta and Mu spike variants. Vaccination during the third trimester induced higher cord-nAb levels at delivery than did infection during the third trimester. In contrast, vaccine-induced nAb levels were lower at the time of delivery compared with infection during the first trimester. The transfer ratio (cord nAb level divided by maternal nAb level) was greatest in mothers vaccinated in the second trimester. SARS-CoV-2 vaccination or infection in pregnancy elicits effective nAbs with differing neutralization kinetics that are influenced by gestational time of exposure.

Indexed as

COVID-19SARS-CoV-2Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesFemaleGestational AgeHumansMothersNeutralization TestsVaccinationAntibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesAdaptive immunityCOVID-19ImmunoglobulinsInfectious disease

Identifiers

PMID35579965
PMCPMC9309042
OpenAlexW4280582151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.